Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (281-290 of 578) with videos related to

Pageof 58
Sort By:
Brachytherapy|October 17, 2025
Combined operative and radiotherapeutic treatment for locally recurrent gynaecologic cancer with pelvic wall invasion: A monocentric retrospective studySelnur Özkurt, Eva Oldenburger, Vincent Tambeur, et al.
Journal of the National Cancer Institute|January 17, 2003
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trialJ Baptist Trimbos, Ignace Vergote, Giorgio Bolis, et al.
Gynecologic Oncology|October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancerEvelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
The New England Journal of Medicine|March 29, 2012
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancerJonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
Gynecologic cancers in pregnancy: guidelines of an international consensus meetingFrédéric Amant, Kristel Van Calsteren, Michael J Halaska, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2014
Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatmentEvelyn Despierre, Betül T Yesilyurt, Sandrina Lambrechts, et al.
Gynecologic Oncology|February 18, 2022
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancerAdriaan Vanderstichele, Liselore Loverix, Pieter Busschaert, et al.
Molecular Cancer|March 25, 2014
Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortiumStefanie Aust, Katharina Auer, Anna Bachmayr-Heyda, et al.
Breast Cancer Research : BCR|February 23, 2012
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteersEleni van Schooneveld, Maartje Ca Wouters, Ilse Van der Auwera, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial CancerPatricia Pautier, Ignace Vergote, Florence Joly, et al.
Pageof 58

Showing results (281-290 of 578) with videos related to

Sort By:
Pageof 58
Brachytherapy|October 17, 2025
Combined operative and radiotherapeutic treatment for locally recurrent gynaecologic cancer with pelvic wall invasion: A monocentric retrospective studySelnur Özkurt, Eva Oldenburger, Vincent Tambeur, et al.
Journal of the National Cancer Institute|January 17, 2003
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trialJ Baptist Trimbos, Ignace Vergote, Giorgio Bolis, et al.
Gynecologic Oncology|October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancerEvelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
The New England Journal of Medicine|March 29, 2012
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancerJonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
Gynecologic cancers in pregnancy: guidelines of an international consensus meetingFrédéric Amant, Kristel Van Calsteren, Michael J Halaska, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2014
Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatmentEvelyn Despierre, Betül T Yesilyurt, Sandrina Lambrechts, et al.
Gynecologic Oncology|February 18, 2022
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancerAdriaan Vanderstichele, Liselore Loverix, Pieter Busschaert, et al.
Molecular Cancer|March 25, 2014
Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortiumStefanie Aust, Katharina Auer, Anna Bachmayr-Heyda, et al.
Breast Cancer Research : BCR|February 23, 2012
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteersEleni van Schooneveld, Maartje Ca Wouters, Ilse Van der Auwera, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial CancerPatricia Pautier, Ignace Vergote, Florence Joly, et al.
Pageof 58